G-Protein Coupled Receptors Market Poised for 7 % Growth, Set to Hit $4.46 Billion by 2029

How Are the key drivers contributing to the expansion of the g-protein coupled receptors market?
The G-protein-coupled receptors market is anticipated to grow due to the escalating incidence of cancer. Cancer, a disease characterized by the uncontrolled spread and infection of abnormal cells in surrounding tissues, can also disseminate through the body's lymphatic and vascular systems. GPCRs are crucial in managing the processes identified as the hallmarks of cancer, such as proliferative signaling, replicative immortality, evasion of growth suppressors, resistance to cell death, and the initiation of invasion and metastasis. For example, the US-based professional organizations company, the American Cancer Society, reported that there were 1,958,310 new cancer diagnoses in the United States in January 2023, marking an increase from the projected 1.9 million new cases in 2022. As a result, the escalating incidence of cancer fuels the growth of the G-protein coupled receptors market.

Get Your G-Protein Coupled Receptors Market Report Here:
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

What growth opportunities are expected to drive the g-protein coupled receptors market's CAGR through 2034?
The G-protein coupled receptors industry has experienced robust growth in the past few years. The market, which was valued at $3.2 billion in 2024, is projected to reach $3.41 billion in 2025, registering a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this growth during the historical period include advancements in drug discovery, approvals from the FDA, genomic discoveries, emerging markets, market consolidation, and an increasing aging population.

The market for G-protein coupled receptors is projected to experience substantial growth in the coming years. It is anticipated to reach a value of $4.46 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is predicted to be driven by factors such as the rise of personalized medicine, greater focus on rare diseases, the use of artificial intelligence in drug discovery, patient-oriented drug development, environmental and societal factors, and growth in the biosimilar market. Significant trends expected during this forecast period include advancements in biotechnology, increased investment in research and development, technological innovations, partnerships and collaborations, and digital therapeutics.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

What are the emerging trends shaping the future of the g-protein coupled receptors market?
Increasing investment to enhance screening procedures and antibody development for G-Protein-Coupled Receptor (GPCR) is a trend emerging in the GPCR market. Leading companies in this field are striving towards procuring sufficient investment to further develop drugs and associated mechanisms to combat GPCR-related conditions. For example, in February 2023, LifeArc Ventures, a venture capital company based in the UK, invested $16 million in Maxion Therapeutics, a drug discovery company also from the UK, to augment the development of antibodies for previously incurable ion channel and GPCR-related disorders. This investment will facilitate the progress of antibody therapeutics which target ion channels and GPCRs, making use of KnotBody technology. This inventive platform enables the investigation of biologicals against ion channels and GPCRs with the help of naturally existing cysteine-rich mini proteins. Furthermore, a US-based biotech company named Septerna Inc. has announced its inception alongside Series A funding amounting to $100 million. This initial funding is set to be employed in developing their budding pipeline of progressive GPCR-focused medicinal programs fueled by the Native Complex Platform and spanning various therapeutic sectors.

Which growth-oriented segments of the g-protein coupled receptors market are leading the industry's development?
The G-protein coupled receptors market covered in this report is segmented -

1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands
2) By Assay: CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding And GTP?S Functional Assays, Internalization Assays, Trafficking Assays
3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

Subsegments:
1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines
2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays
3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors
4) By Ligands: Agonists, Antagonists, Inverse Agonists

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11976

What regions are leading the charge in the g-protein coupled receptors market?
North America was the largest region in the G-protein coupled receptors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the G-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the g-protein coupled receptors market?
Major companies operating in the G-protein coupled receptors market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

What Is Covered In The G-Protein Coupled Receptors Global Market Report?

• Market Size Forecast: Examine the g-protein coupled receptors market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the g-protein coupled receptors market for a structured understanding.
• Key Players Overview: Analyze major players in the g-protein coupled receptors market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the g-protein coupled receptors market.
• Segment Contributions: Evaluate how different segments drive overall growth in the g-protein coupled receptors market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the g-protein coupled receptors market.
• Industry Challenges: Identify potential risks and obstacles affecting the g-protein coupled receptors market.
• Competitive Landscape: Review strategic developments in the g-protein coupled receptors market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.